Receive Our Newsletter

High Costs Of Specialty Drugs

By Julie Appleby KHN Staff Writer Aug 22, 2011 This story was produced in collaboration with For Judy Ariba, one of the most harrowing moments in her battle against a rare form of leukemia occurred after she had already endured a long hospital stay and grueling chemotherapy: Her bill for a prescription cancer drug jumped […]

Blood test can identify fetal sex as early as 7 weeks gestation

August 9, 2011 Fetal sex can be determined reliably with a non-invasive genetic test as early as 7 weeks into a pregnancy, according to a new meta-analysis published this week in the Journal of the American Medical Association. The results of the NIH-funded analysis have important implications for early diagnosis of genetic diseases linked to […]

UPDATE 2-Novo Nordisk settles U.S. probe for $25 million

Click here for link to article * Settlement resolves probe into drug marketing practices * Novo Nordisk does not admit wrongdoing in settlement * Company to enter corporate integrity agreement NEW YORK, June 10 (Reuters) – Danish drugmaker Novo Nordisk (NOVOb.CO) will pay $25 million to settle a lawsuit over the alleged improper marketing of […]

Anschutz Medical Campus researchers discover new process to cultivate adult blood cells

Direct link to article By Margaret Jackson The Denver Post Posted: 06/06/2011 01:00:00 AM MDT Updated: 06/06/2011 09:39:32 AM MDT   Research assistant Patti Estes with Taiga Biotechnologies prepares stem cells for an experiment at the Anschutz Medical Campus in Aurora last week. Taiga estimates that it could create new adult blood cells for trials on humans […]

Drugs for rare cancers approved after subpar tests

Direct link to article By Frederik Joelving NEW YORK | Mon Jun 6, 2011 5:39pm EDT (Reuters Health) – Drugs for rare cancers are allowed to hit the U.S. market based on low-quality clinical tests that raise concerns about both safety and efficacy, researchers said Monday. Known as orphan drugs, such medications are used to […]

Viral Outbreaks in Dogs Yield Clues on Origins of Hepatitis C

New York Times article link By CARL ZIMMER Published: May 30, 2011 Hepatitis C is, in some ways, a high-profile disease. Worldwide, an estimated 200 million people are infected with the virus. Some of them will suffer cirrhosis, liver cancer and even death. Celebrities like Steven Tyler of Aerosmith and “American Idol” have spoken publicly […]

FDA approves new HIV treatment

FDA NEWS RELEASE For Immediate Release: May 20, 2011 Media Inquiries: Erica Jefferson, 301-796-4988, Consumer Inquiries: 888-INFO-FDA Click here for a link to the full press release. FDA approves new HIV treatment The U.S. Food and Drug Administration today approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection […]

GTC Biotherapeutics, Inc., a LFB Group Company, Granted Protection until 2027 on Broad Transgenic Protein Production Patent, and is Also Granted New Patent on Recombinant Anti-Thrombin Produced Transgenically

Click here for full Business Wire article FRAMINGHAM, Mass.–(BUSINESS WIRE)–GTC Biotherapeutics, Inc. (GTC) (a wholly-owned subsidiary of LFB Biotechnologies S.A.S., Les Ulis, France), announced today that the United States Patent and Trademark Office (USPTO) granted (to GTC) a patent covering DNA constructs for the production of any therapeutic protein in the milk of any transgenic […]

Merck’s Hepatitis C Drug Wins F.D.A. Approval

Click here for New York Times article. By ANDREW POLLACK Published: May 13, 2011 The Food and Drug Administration approved on Friday the first of a new generation of hepatitis C drugs that promises to increase the cure rate while shortening the time required for treatment. The new drug, Victrelis from Merck, effectively cured more […]

Symposium Menu

HFA Symposium – Women’s Session (Food Demo Menu)

Click the image below to download and print the menu from the Women’s Wellness Session at our 2011 Symposium.

Page 23 of 29« FirstPrevious19202122232425262728NextLast »

Assisting and Advocating for the Bleeding Disorders Community